Two Sigma Advisers’s Palvella Therapeutics, Inc. Common Stock PVLA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-424
| Closed | -$6.21K | – | 2712 |
|
2024
Q1 | $6.21K | Sell |
424
-9
| -2% | -$132 | ﹤0.01% | 2423 |
|
2023
Q4 | $6.3K | Buy |
433
+128
| +42% | +$1.86K | ﹤0.01% | 2470 |
|
2023
Q3 | $7.27K | Buy |
305
+42
| +16% | +$1K | ﹤0.01% | 2352 |
|
2023
Q2 | $3.48K | Sell |
263
-30
| -10% | -$397 | ﹤0.01% | 2356 |
|
2023
Q1 | $22.8K | Sell |
293
-556
| -65% | -$43.3K | ﹤0.01% | 2510 |
|
2022
Q4 | $70.6K | Sell |
849
-285
| -25% | -$23.7K | ﹤0.01% | 2333 |
|
2022
Q3 | $104K | Sell |
1,134
-722
| -39% | -$66.2K | ﹤0.01% | 2305 |
|
2022
Q2 | $278K | Sell |
1,856
-3,257
| -64% | -$488K | ﹤0.01% | 2148 |
|
2022
Q1 | $1.24M | Sell |
5,113
-8,373
| -62% | -$2.03M | ﹤0.01% | 1521 |
|
2021
Q4 | $4.08M | Sell |
13,486
-448
| -3% | -$135K | 0.01% | 857 |
|
2021
Q3 | $5.76M | Buy |
+13,934
| New | +$5.76M | 0.01% | 718 |
|
2021
Q2 | – | Sell |
-345
| Closed | -$71K | – | 2736 |
|
2021
Q1 | $71K | Sell |
345
-156
| -31% | -$32.1K | ﹤0.01% | 2472 |
|
2020
Q4 | $100K | Sell |
501
-102
| -17% | -$20.4K | ﹤0.01% | 2270 |
|
2020
Q3 | $100K | Sell |
603
-801
| -57% | -$133K | ﹤0.01% | 2275 |
|
2020
Q2 | $348K | Buy |
1,404
+125
| +10% | +$31K | ﹤0.01% | 2053 |
|
2020
Q1 | $233K | Sell |
1,279
-74
| -5% | -$13.5K | ﹤0.01% | 2117 |
|
2019
Q4 | $392K | Sell |
1,353
-103
| -7% | -$29.8K | ﹤0.01% | 1969 |
|
2019
Q3 | $397K | Sell |
1,456
-44
| -3% | -$12K | ﹤0.01% | 1805 |
|
2019
Q2 | $564K | Sell |
1,500
-9
| -0.6% | -$3.38K | ﹤0.01% | 1765 |
|
2019
Q1 | $404K | Sell |
1,509
-17
| -1% | -$4.55K | ﹤0.01% | 1873 |
|
2018
Q4 | $325K | Buy |
1,526
+13
| +0.9% | +$2.77K | ﹤0.01% | 1954 |
|
2018
Q3 | $678K | Buy |
1,513
+40
| +3% | +$17.9K | ﹤0.01% | 1672 |
|
2018
Q2 | $597K | Buy |
1,473
+258
| +21% | +$105K | ﹤0.01% | 1852 |
|
2018
Q1 | $663K | Buy |
1,215
+728
| +149% | +$397K | ﹤0.01% | 1717 |
|
2017
Q4 | $294K | Buy |
+487
| New | +$294K | ﹤0.01% | 1951 |
|